Company Overview of Koronis Pharma, Inc.
Koronis Pharma, Inc., a biotechnology company, develops antiviral therapeutics based on Viral Decay Acceleration mechanism. It develops KP-1461 for the treatment of HIV virus; and products for the treatment of antiviral infections. The company was founded in 1998 and is based in Seattle, Washington.
500 Union Street
Seattle, WA 98101
Founded in 1998
Key Executives for Koronis Pharma, Inc.
Similar Private Companies By Industry
|Berkeley Bioengineering Co.||United States|
|CMC ICOS Biologics Inc.||United States|
|Cognate BioServices, Inc.||United States|
|PPD Discovery||United States|
|Flagship Biosciences L.L.C.||United States|
Recent Private Companies Transactions
October 30, 2013
Most Searched Private Companies
|Company Name||Geographic Region|
|NYC2012, Inc.||United States|
|Lawyers Committee for Civil Rights Under Law||United States|
|Rush University||United States|
|Greater Houston Partnership||United States|
Post a JobJobs
- San Mateo, CA |Posted: Apr 05
- San Francisco, CA | Investment Firm Providing Private and Institutional BrokeragePosted: Apr 07
- Kansas City, MO | SkillsniperPosted: Apr 14
- New York | Leading Financial Institution of CanadaPosted: Mar 05
Sponsored Financial Commentaries
To contact Koronis Pharma, Inc., please visit www.koronispharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.